CheckPath AML is an online activity consisting of 4 cases focusing on AML, incorporating virtual slides and digital images.
The activity offers 4 CME, CMLE, or SAMs CME credits. In addition, the activity also meets requirements for MOC Part IV Performance in Practice.
There have been recent, significant advances in the diagnosis and management of AML, which warrant ongoing
education for the interdisciplinary care team involved in the management of patients with AML. CheckPath AML is part of an AML educational initiative that will provide guidance to the interdisciplinary AML care team on the optimal diagnosis and classification of AML, risk stratification, and individualized treatment selection, assessment of treatment responses, monitoring for and mitigation of adverse events, and patient education regarding prognosis and treatment choices.
· Assess diagnostic skills and differential diagnoses relevant to the study cases presented in AML.
· Evaluate appropriate ancillary testing methodology relevant to the study cases in AML.
· Identify areas of the practice of AML relevant to the study cases where criteria or classification may have undergone recent changes, new disease entities may have emerged, or where new developments involving pathologic work up may impact therapy.
The American Society for Clinical Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The ASCP designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a .m. to 6 p.m. Eastern Time
Method of Participation
To complete the activity and receive credit, the participant must complete the online course. CME certificates will be provided on-line.
Funded by an independent educational grant from the Celgene Corporation.